Best (And Worst) Peptides to Experiment With in 2026: Complete Tier List

I have been getting asked to do a peptides tier list for over a year. The reason I kept putting it off is because tier lists are inherently reductive - a compound that is S-tier for fat loss might be C-tier for recovery. Context matters. But after enough questions from clients and viewers, I decided to do it properly.

This tier list is based on three criteria: clinical evidence quality, real-world results I have seen in clients, and risk-to-reward ratio. A compound can have great clinical data but terrible side effects that make it impractical. A compound can have limited human trials but strong mechanistic data and years of anecdotal evidence. I weight all of it.

I am going to cover every major peptide available right now - the fat loss compounds, the GH secretagogues, the healing peptides, the experimental ones people are asking about. I will tell you exactly where each one sits and why.

Some of these rankings will surprise you. Some will confirm what you already suspected. Either way, this is my honest assessment based on what I have seen work and what I have seen fail.

S-Tier Peptides: Best in Class

Retatrutide sits alone at the top. Nothing else in the peptide space currently produces the fat loss results that retatrutide delivers. Triple agonist mechanism targeting GLP-1, GIP, and glucagon simultaneously. Clinical trial data showing 24% body weight reduction at higher doses over 48 weeks. The risk profile is manageable when titrated correctly. For anyone whose primary goal is significant fat loss and metabolic optimization, retatrutide is the clear S-tier compound.

BPC-157 also belongs in S-tier, though for completely different reasons. The breadth of what BPC-157 does is remarkable - gut healing, tendon and ligament repair, neurological protection, angiogenesis, systemic inflammation reduction. The clinical evidence for the gut and healing applications is strong. It costs very little, side effects are minimal, and the applications are broad. For general recovery and longevity, nothing touches it at its price point.

A-Tier Peptides: Highly Effective

CJC-1295 with ipamorelin is my top A-tier stack. Clean GH stimulation without the cortisol and prolactin issues of older GHRPs. The combination hits GHRH and GHRP receptors simultaneously for a synergistic GH pulse. Sleep quality, recovery, body composition, and skin all improve. The only reason it is not S-tier is that it is a supporting compound - it optimizes your GH axis but does not fundamentally drive the kind of transformation that retatrutide does on its own.

TB-500 (Thymosin Beta-4 synthetic fragment) belongs in A-tier for recovery applications. Tissue repair, inflammation reduction, and flexibility improvements are real and well-documented. Athletes with chronic injuries often see results that nothing else provides. The research base is solid and the safety profile is excellent.

B-Tier Peptides: Solid but Situational

Ipamorelin used alone without CJC-1295 drops to B-tier. It still provides good GH stimulation and is extremely clean in terms of side effects, but you are leaving results on the table by not pairing it with a GHRH analog. As a standalone, it is solid. Paired with CJC-1295, it jumps to A-tier.

PT-141 (bremelanotide) is a legitimate B-tier compound for sexual health applications - both libido enhancement in men and women and erectile function. The clinical evidence is there, it is FDA-approved for hypoactive sexual desire disorder in women, and the mechanism through melanocortin receptors is well understood. Side effects including nausea and temporary blood pressure elevation keep it out of A-tier.

Sermorelin has decades of clinical use and a solid safety record. GH stimulation is gentler than CJC-1295, which makes it appropriate for older populations or those who want a more conservative approach. Results are slower but very consistent over longer cycles.

C-Tier Peptides: Limited or Overhyped

GHRP-6 and GHRP-2 are C-tier in 2026. They were staples 10-15 years ago, but they have been superseded. Both cause cortisol and prolactin spikes that are absent with ipamorelin. GHRP-6 triggers significant hunger, which is counterproductive in a fat loss context. There is nothing wrong with them mechanistically, but why use an older, less clean compound when better options exist?

HGH Fragment 176-191 gets a lot of hype but underwhelms in practice. The theory is appealing - isolate the fat-mobilizing portion of growth hormone without the growth-promoting effects. The reality is that the clinical evidence is limited, absorption is variable, and the fat loss results rarely match expectations. At best it is a mild addition to a more robust stack.

Selank and Semax are interesting nootropic and anxiolytic peptides with some solid research from Russia, but the translation to widespread human clinical use is limited. Not bad, just not where I would put most clients' money.

D-Tier Peptides: Poor Risk-Reward

Melanotan II sits firmly in D-tier. Yes, it produces a tan and has aphrodisiac effects at high doses. It also causes significant nausea, facial flushing, involuntary erections, and has been linked to concerning mole darkening and potential melanoma risk signals in some studies. The risks are not worth the cosmetic benefits. PT-141 provides the libido benefits with a far better safety profile.

Follistatin-344 and ACE-031 are experimental compounds with serious safety flags. The muscle-building potential is real but the mechanisms involve blocking myostatin, and the uncontrolled, systemic nature of these effects raises serious concerns about cardiac muscle and organs beyond skeletal muscle. These are not ready for responsible human use.

F-Tier: Avoid

AOD-9604 was heavily marketed as a fat loss peptide in the early 2010s. It failed to demonstrate meaningful efficacy in Phase 3 human trials for obesity treatment. The preclinical data was promising, but the human data did not hold up. Spending money on this when retatrutide, semaglutide, or tirzepatide exist makes no sense.

CJC-1295 without DAC (also sold as Mod GRF 1-29) taken in isolation with poor timing protocols delivers disappointing results and causes confusion when people compare it to CJC-1295 with DAC. The lack of standardization in sourcing and confusion around naming conventions makes this particularly problematic for consumers. The DAC version is far more practical.

Any peptide from an unverified source without third-party COA testing effectively becomes F-tier regardless of what it is supposed to be. Peptide purity is a serious issue and unlabeled or mislabeled compounds are common in the gray market.

How to Choose Based on Your Goals

Fat loss priority: Start with retatrutide. Stack with CJC-1295/ipamorelin to protect muscle and optimize GH. Add BPC-157 for recovery. That stack covers every major fat loss mechanism.

Muscle and performance priority: CJC-1295 with ipamorelin as the foundation. Add BPC-157 for recovery and joint health. If injury is a concern, add TB-500 for the active repair phase.

Longevity and anti-aging priority: BPC-157 daily as the backbone. CJC-1295/ipamorelin for GH optimization and sleep quality. Sermorelin is a conservative alternative for GH stimulation if you want a gentler approach.

Sexual health: PT-141 as needed. Ensure your testosterone is optimized first - PT-141 works much better when your hormonal foundation is solid.